Both in Biotechnology
Vaxcyte vs Repligen
Over the past year PCVX returned +41.5% and RGEN returned +15.2%; their daily moves had a correlation of 0.23.
PCVX +41.5% RGEN +15.2%Growth of $1, one year, split-adjusted
| Metric | PCVX | RGEN |
|---|---|---|
| Price | $60.62 | $172.95 |
| Market cap | $9.54B | $10.98B |
| Today | −2.27% | −2.25% |
| 1 month | +7.3% | −4.8% |
| 6 months | +3.6% | +46.3% |
| Year to date | +31.4% | +5.5% |
| 1 year | +35.5% | +19.6% |
| Revenue growth (YoY) | — | +10.9% |
| Gross margin | — | 53.0% |
| Net margin | — | −18.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 13.6× |
| Net cash | $1.49B | $307.4M |
| Dividend yield | — | — |
| Volatility (60d) | 70.6% | 47.0% |
| Short % of float | 11.2% | 12.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).